Page 3 - Organ Dysfunction News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) exhibits variable immunity responses among hosts based on symptom severity. Whether immunity in recovered individuals is effective for avoiding reinfection is poorly understood. Determination of immune memory status against SARS-CoV-2 helps identify reinfection risk and vaccine efficacy. Hence, after recovery from COVID-19, evaluation of protective effectiveness and durable immunity of prior disease could be significant. Recent reports described the dynamics of SARS-CoV-2 -specific humoral and cellular responses for more than six mon...

The FDA issued the final guidance document for first-in-human trial designs that consist of both dose escalation as well as multiple expansion...

The FDA issued the final guidance document for first-in-human trial designs that consist of both dose escalation as well as multiple expansion...

Beyond issuing guidance documents, what actions has the FDA taken to ensure inclusion of relevant patient populations in cancer clinical trials? And...

Beyond issuing guidance documents, what actions has the FDA taken to ensure inclusion of relevant patient populations in cancer clinical trials? And...